GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (OSTO:SEZI) » Definitions » Cyclically Adjusted PS Ratio

Senzime AB (OSTO:SEZI) Cyclically Adjusted PS Ratio : 40.94 (As of Jun. 09, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Senzime AB Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Senzime AB's current share price is kr6.96. Senzime AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was kr0.17. Senzime AB's Cyclically Adjusted PS Ratio for today is 40.94.

The historical rank and industry rank for Senzime AB's Cyclically Adjusted PS Ratio or its related term are showing as below:

OSTO:SEZI' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 21.43   Med: 82.58   Max: 277.26
Current: 41.9

During the past years, Senzime AB's highest Cyclically Adjusted PS Ratio was 277.26. The lowest was 21.43. And the median was 82.58.

OSTO:SEZI's Cyclically Adjusted PS Ratio is ranked worse than
98.32% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.17 vs OSTO:SEZI: 41.90

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Senzime AB's adjusted revenue per share data for the three months ended in Mar. 2024 was kr0.101. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is kr0.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Senzime AB Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Senzime AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Cyclically Adjusted PS Ratio Chart

Senzime AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 229.39 85.68 46.74

Senzime AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.48 20.96 45.59 46.74 37.32

Competitive Comparison of Senzime AB's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Senzime AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senzime AB's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Senzime AB's Cyclically Adjusted PS Ratio falls into.



Senzime AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Senzime AB's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=6.96/0.17
=40.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senzime AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Senzime AB's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.101/132.2054*132.2054
=0.101

Current CPI (Mar. 2024) = 132.2054.

Senzime AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.011 100.432 0.014
201409 0.001 100.161 0.001
201412 0.003 100.225 0.004
201503 0.003 99.950 0.004
201506 0.002 99.995 0.003
201509 0.002 100.228 0.003
201512 0.002 100.276 0.003
201603 0.001 100.751 0.001
201606 0.022 101.019 0.029
201609 0.028 101.138 0.037
201612 0.005 102.022 0.006
201703 0.000 102.022 0.000
201706 0.004 102.752 0.005
201709 0.000 103.279 0.000
201712 0.000 103.793 0.000
201803 0.000 103.962 0.000
201806 0.008 104.875 0.010
201809 0.003 105.679 0.004
201812 0.058 105.912 0.072
201903 0.008 105.886 0.010
201906 0.024 106.742 0.030
201909 0.048 107.214 0.059
201912 0.051 107.766 0.063
202003 0.048 106.563 0.060
202006 0.020 107.498 0.025
202009 0.036 107.635 0.044
202012 0.059 108.296 0.072
202103 0.023 108.360 0.028
202106 0.069 108.928 0.084
202109 0.023 110.338 0.028
202112 0.059 112.486 0.069
202203 0.038 114.825 0.044
202206 0.053 118.384 0.059
202209 0.053 122.296 0.057
202212 0.065 126.365 0.068
202303 0.100 127.042 0.104
202306 0.102 129.407 0.104
202309 0.100 130.224 0.102
202312 0.089 131.912 0.089
202403 0.101 132.205 0.101

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Senzime AB  (OSTO:SEZI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Senzime AB Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Senzime AB's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Senzime AB (OSTO:SEZI) Business Description

Traded in Other Exchanges
Address
Ulls vag 41, Uppsala, SWE, 756 51
Senzime AB, a medical technology company, develops, manufactures, and markets patient monitoring systems for monitoring patients. Its solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease healthcare costs. Its product includes TetraGraph and TetraSens, ExSpiron, TetraSens Pediatric, and TetraConnect. Its geographical segments include Sweden, the United States, Europe/Oceania, and Asia.

Senzime AB (OSTO:SEZI) Headlines

No Headlines